Find your next paid study

Pay not disclosed — ask the coordinator

NYU Langone HealthNCT07076238

Comparison of Power Training Progression Methods in Older Independently Living Adults.

This study will investigate the impact of two unique progression models for power training in a sample of healthy older adults. The objective is to identify th…

Activity, Motor

University of MiamiNCT07378826

Actual pay is set by the research site.

Phase 4

Arthroscopic Rotator Cuff Repair Augmented With Bioinductive Implant for Full-Thickness Tears: A Randomized Controlled Study

The purpose of this randomized-controlled study is to compare outcomes of arthroscopic rotator cuff repair augmented with a Bioinductive Implant (study group) …

Rotator Cuff TearsRotator Cuff Tear Arthropathy

Henry Ford Health SystemNCT05439850

~$25 – $1,000

Actual pay is set by the research site.

A Phase II Study of Total Consolidative Metastasis-and-primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC).

This is a non-randomized, open-label phase II study designed to estimate 12-month treatment-free survival rate following total consolidative metastasis-and-pri…

Renal Cell Carcinoma

Abramson Cancer Center at Penn MedicineNCT06770855

Actual pay is set by the research site.

Phase 1

Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury

The main goal of this study is to determine if psilocybin is safe for use in people with SCI. The study will measure how people with SCI respond to three psilo…

Spinal Cord InjuryDepression - Major Depressive DisorderVeteran

James J. Peters Veterans Affairs Medical CenterNCT07251491

~$150 – $2,700

Actual pay is set by the research site.

Phase 4

A Phase 4, Randomized, Open Label Study to Evaluate the Safety and Tolerability of Twice Daily Xanomeline/Trospium Chloride (KarXT) With Prophylactic and PRN Antiemetic Use in Healthy Volunteers

This study looks at how to reduce nausea and vomiting in people taking KarXT which is used to treat mental health conditions like schizophrenia. KarXT can caus…

Healthy Volunteers

Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT07681076

~$25 – $1,400

Actual pay is set by the research site.

Ifluence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effect

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (…

Smoking Behaviors

Roswell Park Cancer InstituteNCT07102082

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

A Phase I, Open-label, Dose Finding, Safety, Tolerability and Exploratory Trial of THEO-260 Administered Via an Intraperitoneal Route in Patients With High Grade Serous or Endometrioid Ovarian Cancer

A research study evaluating a new oncolytic virus, THEO-260, in patients with advanced ovarian cancer. The trial will investigate different doses of THEO-260 a…

Ovarian Cancer

Theolytics LimitedNCT07211659

~$150 – $4,200

Actual pay is set by the research site.

Prospective Validation of a Reduced-Montage TMS-EEG Complexity Algorithm (Presence-IP1.0) to Differentiate Conscious and Unconscious States Across Wakefulness and Sleep

This study aims to validate a novel real-time algorithm (Presence-IP1.0) designed to detect consciousness from TMS-evoked EEG responses using a reduced electro…

Sleep

University of Wisconsin, MadisonNCT07523191

Actual pay is set by the research site.

Community Team Lifestyle Immersion Program for Chronic Disease Prevention and Control

This project is focuses on reducing the risk and progression of hypertension among a population that records high incidence of hypertension and other chronic a…

Hypertension

Meharry Medical CollegeNCT07201948

Actual pay is set by the research site.

Phase 1

A Phase 1/2, Multicenter, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KK2430 in Participants With Hematologic Neoplasms

KK2430 ("Study Drug") as a potential treatment for people with Hematologic Neoplasms. KK2430 is an experimental drug; it has not been approved for the treatmen…

Hematologic Neoplasms

Kyowa Kirin Co., Ltd.NCT07629726

~$150 – $4,200

Actual pay is set by the research site.

Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

An observational study of patients with hematologic, oncologic, and other relevant conditions undergoing bone marrow imaging, with longitudinal collection of i…

HematologicOncologicBone Marrow